Barely Significant
← all excerpts

Comparison of <sup>64</sup>Cu-DOTA-PSMA-3Q and <sup>64</sup>Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imaging.

Eur J Nucl Med Mol Imaging · 2025 · PMC12162759 · PMID 39954062

Europe PMCDOI
1
hedged sentence
0.1340
closest p · 2.7× alpha
0.1340
boldest claim

The sentences

did not reach statistical significanceP = 0.134not close (p > 0.1)
Spleen uptake was also higher for 64 Cu-DOTA-PSMA-3Q (1.28 ± 0.44% ID/g) than for 64 Cu-NOTA-PSMA-3Q (0.73 ± 0.25% ID/g), but this difference did not reach statistical significance ( P = 0.134).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.